The Gary Null Show

The Gary Null Show

By Progressive Radio NetworkAlternative HealthHealth & Fitness
Download on the App Store
  • Ranking

    43rd

    on Alternative Health

  • Favorites

    353

    Followers

  • Typical duration

    62 min

    per episode

  • If it hooks

    54%

    finish an episode

Based on Podcast App listening data

The Gary Null Show episodes

  • The Gary Null Show - 11.02.22
    VIDEOS:
    Mark Dolan: Covid has been the biggest “I told you so” in history (4:41)
    Society is going to COLLAPSE (5:24)
    Fear Psychosis and the Cult of Safety – Why are People so Afraid? (13:25)
    MSNBC Midterm PANIC꞉ ‘It’s Going To Be a BLOODBATH’!!! (0:18 – 3:32)
    Pycnogenol, gotu kola supplementation associated with decreased progression of atherosclerosisD’Annunzio University (Italy), October 23, 2022
    The results of studies published in Minerva Cardioangiologica suggest a benefit for supplementation with extracts of pine bark and the herb gotu kola in atherosclerosis.
    In one study, participants with arterial wall atherosclerotic lesions and intima-media thickening (thickening of the artery walls’ innermost layers) received standard management, standard management plus aspirin, or standard management, aspirin and Pycnogenol® pine bark extract plus gotu kola extract daily for three years, after which atherosclerotic lesion progression, carotid artery intima-media thickness and oxidative stress were assessed.
    At the end of the trial, 5.3% of those who received Pycnogenol and gotu kola had experienced atherosclerotic lesion progression in comparison with over 20% of the remainder of the participants. Cardiovascular events that required hospital admission were less than 4% in the supplemented group compared to over 12% in the rest of the subjects. Carotid artery intima thickness and oxidative stress were also lower in association with supplementation.
    In the second study, 90 men with coronary artery calcifications received standard management alone, standard management and daily Pycnogenol, or standard management with daily Pycnogenol plus gotu kola. All participants received daily aspirin. Calcification was assessed at the beginning of the study and after one year.
    While Pycnogenol plus standard management was more effective than standard management alone, men who received Pycnogenol plus gotu kola experienced a 10% decline in the number of calcifications by the end of the study, in contrast with a 34.9% increase in the standard management group. “This indicates that supplementation with the combined supplements blocks the increase in calcified areas and, possibly, in time may decrease the number of calcified spots,” Shu Hu and colleagues write.
    Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study.Pennsylvania State University, October 22, 2022Nut consumption lowers cardiovascular disease (CVD) risk. Studies are lacking about the effects of pistachios, a nutrient-dense nut, on CVD risk factors, dose-response relations, and lipid-lowering mechanisms.
    We evaluated the effects of 2 doses of pistachios, added to a lower-fat diet, on lipids and lipoproteins, apolipoprotein (apo)-defined lipoprotein subclasses, and plasma fatty acids. To investigate the mechanisms of action, we measured cholesteryl ester transfer protein and indexes of plasma stearoyl-CoA desaturase activity (SCD).
    In a randomized crossover controlled-feeding study, 28 individuals with LDL cholesterol > or = 2.86 mmol/L consumed 3 isoenergetic diets for 4 wk each. Baseline measures were assessed after 2 wk of a typical Western diet. The experimental diets included a lower-fat control diet with no pistachios [25% total fat; 8% saturated fatty acids (SFAs), 9% monounsaturated fatty acids (MUFAs), and 5% polyunsaturated fatty acids (PUFAs)], 1 serving/d of a pistachio diet (1 PD; 10% of energy from pistachios; 30% total fat; 8% SFAs, 12% MUFAs, and 6% PUFAs), and 2 servings/d of a pistachio diet (2 PD; 20% of energy from pistachios; 34% total fat; 8% SFAs, 15% MUFAs, and 8% PUFAs).
    Inclusion of pistachios in a healthy diet beneficially affects CVD risk factors in a dose-dependent manner, which may reflect effects on SCD.
    Poor quality sleep may be linked to heightened risk of glaucoma, irreversible sight lossSichuan University (China), November 1, 2022
    Poor quality sleep, including too much or too li
    1 hr 2 min
  • The Gary Null Show - Interview With Michael Hudson
    Dr. Michael Hudson is one of our nation’s finest and most important economists and Wall Street financial analysts. Dr. Paul Craig Roberts has called Michael “the world’s best economist.” He is the President of The Institution for the Study of Long-Term Economic Trends, and a distinguished research professor of economics at the University of Missouri. He was the Chief Economic Policy Advisor for the Rep. Dennis Kucinich’s 2008 presidential campaign and has served as an adviser to the White House, State and Defense departments and served as an economic advisor to other governments including Iceland, Latvia and China.  Michael has written many books and important papers and articles. His most recent must-read book is "The Destiny of Civilization: Finance Capitalism, Industrial Capitalism or Socialism" which explains the reason for crisis in the US and other Western nations due to a drainage o income, indebtedness and a collapse of industrialization. His website is Michael-Hudson.com
    37 min
  • The Gary Null Show - 11.01.22
    Videos:
    Dad STUNS School Board When He Reads Aloud DISGUSTING Book From Library (3:37)
    RFK : The Real Anthony Fauci Clip (1st clip 5:50 – 2nd Clip 4:37)
    Dr. Michael Hudson Interview 
    Neil Oliver: We are expected to forget those promising to fix the disaster caused it (10:28)
    Almonds can help support the gut microbiome, study claimsKings College London, October 31, 2022A new study finds that eating 56 grams of almonds daily — the equivalent of approximately 46 almonds — can improve gut health by promoting levels of butyrate.The research involved three groups replacing their regular snacks with whole almonds, ground almonds, or an energy-equivalent control muffin.The authors conclude that incorporating almonds into the diet could be a way of increasing fiber intake without triggering gut symptoms.An important player in gut health appears to be butyrate, a short-chain fatty acid that supports the health of the microbiome itself.
    Dr. Alice Creedon explained to Medical News Today: “Butyrate is important to gut health, as it acts as the primary source of fuel for the cells of the colon, allowing them to function correctly and optimally. It is also involved in signaling to the gut to initiate the process of nutrient absorption.”
    “In addition,” said Dr. Creedon, “butyrate produced in the gut can enter the bloodstream where it is involved in the regulation of health in other areas of the body, such as the liver, brain, and lungs.”
    The study demonstrates that eating a healthy handful of almonds each day promotes the production of butyrate.
    Dr. Creedon’s research documents the benefits of eating about 56 grams, or 2 ounces, of almonds daily — that amounts to about 46 almonds.
    “Butyrate supports the gut barrier, which keeps bacteria and other microbes from entering your blood. In doing so, butyrate can help to reduce inflammation, manage conditions like IBS [irritable bowel syndrome], and decrease gastrointestinal discomfort like bloating.
    “Butyrate is produced through the fermentation of fiber in the colon. Therefore, increasing fiber in the diet, such as in almonds, increases butyrate levels, which has a positive effect on our gut health,” said Tallman.
    Additional benefit of omega-3 fatty acids for the clearance of metabolites from the brain
    Federation of American Societies for Experimental Biology, October 23, 2022
    New research published online in The FASEB Journal suggests that omega-3 polyunsaturated fatty acids, which are found in fish oil, could improve the function of the glymphatic system, which facilitates the clearance of waste from the brain, and promote the clearance of metabolites including amyloid-β peptides, a primary culprit in Alzheimer’s disease.
    To make this discovery, scientists first used transgenic fat-1 mice, which express high endogenous omega-3 polyunsaturated fatty acids (PUFAs) in the brain, to investigate the effect of omega-3 PUFAs on the clearance function of the glymphatic system. Compared to the wild-type mice, the fat-1 mice with enriched endogenous omega-3 PUFAs significantly promote the clearance function of the lymphatic system, including the Aβ clearance from the brain. Wild-type mice were supplemented with fish oil, which contains high concentrations of omega-3 PUFAs, and found that fish oil-supplemented mice also improved the clearance function of the glymphatic system compared to the control mice without fish oil supplementation. Omega-3 PUFAs help maintain the brain homeostasis, which may provide benefits in a number of neurological diseases, such as Alzheimer’s disease, traumatic brain injury, and sleep impairment, among others.
    “These now-famous fatty acids have been the subject of major studies both in academia and industry. Just when we thought we had heard everything, here is something new, and it is provocative indeed,” said Thoru Pederson, Ph.D., Editor-in-Chief of The FASEB Journal. “This study should not turn attention away from the roles of these substances in maintaining vas
    1 hr 1 min
  • The Gary Null Show - 10.31.22
    Videos:
    Member of The FDA Vax Panel Said “We Are Killing More People Than We Are Saving With The Shots”
    RFK : The Real Anthony Fauci Clip (1st clip 5:50 – 2nd Clip 4:37)
    Dr Shoemaker – C19 vaxx – lethal short and long term 10/22/22 (13:00)
    Clare Daly Latest Top 7 Contributions in the EU. (Start @ 4:32)
    Neil Oliver: We are expected to forget those promising to fix the disaster caused it (10:28)
    MASSIVE GLACIER MELTDOWN THREATENS CIVILIZATION | Countdown to Armageddon (7:42)
    Chlorophyllin shows promise for inflammatory bowel disease
    Sichuan University (China) & Cedars Sinai Medical Center, October 28 2022. 
    The August 2022 issue of the American Journal of Physiology Gastrointestinal and Liver Physiology reported research which found that supplementation with chlorophyllin suppressed intestinal inflammation in a mouse model of inflammatory bowel disease (IBD). 
    Chlorophyllin is a water-soluble derivative of chlorophyll, the pigment that gives green plants their color. “Consuming green-colored vegetables or green pigment supplement such as chlorophyllin might help people with inflammatory bowel disease,” senior author Xiaofeng Zheng, PhD, of Sichuan University West China Hospital in Chengdu, China predicted. 
    Current treatments for inflammatory bowel diseases include immunosuppressant medications and surgery, both of which are associated with potentially serious adverse effects. “The study was designed to determine the effect of safe agents that are easily available to have a beneficial effect in inflammatory bowel disease,” commented report coauthor Stephen J. Pandol, MD, of Cedars Sinai Medical Center in Los Angeles.
    The team induced colitis in mice by administering dextran sulfate sodium. They found that supplementing the animals’ diets with chlorophyllin or directly administering the compound suppressed intestinal inflammation and downregulated disease-associated autophagy in the intestine. 
    “What we found in the study was that the agent used, chlorophyllin, would inhibit the inflammation and tissue damage that occurs in an experimental model of colitis,” Dr Pandol commented. “In this case it was in a mouse model. The results were promising in an experimental model, and those can justify a clinical trial.”
    Curcumin Prodrug Shows Promise As Cancer Treatment Without Toxic Side Effects
    Kyoto University (Japan), October 30, 2022
    Curcumin, the biologically active compound found in turmeric, has shown lots of promise in clinical cancer research. A new study from Kyoto University adds more evidence that supports its use in clinical-care settings. Researchers are developing a curcumin prodrug called TBP1901 that demonstrates anti-tumor effects without adverse toxicities.
    Curcumin is an appealing compound for oncology researchers, as many current pharmacological treatments lead to significant side effects in patients. Thus far, anecdotal findings report strong efficacy when taken orally among cancer patients. However, until this recent development, curcumin’s low bioavailability and instability has put limitations on its clinical use.
    Kanai and team have maneuvered their way around this by successfully identifying the enzyme GUSB, which may activate curcumin to increase its bioavailability. The enzyme plays a crucial role in TBP1901 conversion to curcumin. However, the research team hypothesized that the conversion wouldn’t be observable in mice with genetically-weakened GUSB enzyme.
    Further, they were able to confirm through analysis with CRISPR-Cas9 screening that curcumin may also have additional specific therapeutic targets. “The high conversion rate of TBP1901 to curcumin in bone marrow warrants its clinical application for diseases growing in the marrow like multiple myeloma and leukemia,” states Kanai.
    Now that scientists have begun to crack the code with curcumin, the cancer field may start to put things into motion as more targets and enzymatic processes are explained. 
    Study Reveals How Turmeric Inhibits Pancreati
    1 hr 4 min
  • The Gary Null Show - 10.28.22
    Researchers find Cordyceps used in traditional medicine can fight cancerShanghai Institutes for Biological Sciences, October 23, 2022
    Chinese scientists have found evidence that a fungus used in traditional Chinese medicine widely sought by the public for its healing powers, also carries anti-cancer benefits.
    The scientists found there was an interaction between two anti-cancer compounds in the fungus Cordyceps militaris.
    The first, cordycepin, was noted in Cordyceps militaris in 1950, but how it interacted remained unknown. The second, pentostatin, was first identified from a bacterium and was developed as a commercial drug to treat leukemia and other cancers in the 1990s.
    “For the first time, we decoded the biosynthesis mechanism of cordycepin in the fungus, and during the research we unexpectedly discovered pentostatin,” said Wang Chengshu, head of the research team at the Institute of Plant Physiology and Ecology, a branch of the Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences.
    “These two compounds coexist in fungal cells in the form of a protector and protege – that is to say, cordycepin is synthesized with the coupled production of pentostatin to protect the stability of the former,” he said.
    Their research also showed that the fungus initiates a detoxification process when the cordycepin in the body reaches an excessively high level, which can be toxic.
    Cordyceps fungi are popular in China for their widely believed immunity-enhancing and energy-strengthening properties. Their uses in medical treatment date to the Compendium of Materia Medica, a book widely deemed the encyclopedia of traditional Chinese medicine written in the Ming Dynasty (1368-1644).
    Omega-3 fatty acid could boost IQ for preterm babiesSouth Australian Health and Medical Research Institute, October 27, 2022
    New research from SAHMRI has found a link between the omega-3 fatty acid known as docosahexaenoic acid (DHA) and increased IQ among children born prematurely.
    Preterm children are more likely to have lower IQ scores and cognitive impairments compared with term-born children.
    Dr. Jacqueline Gould, who led the study now published in the New England Journal of Medicine, says infants born at the earliest gestations are deprived of the natural supply of DHA that normally builds up in the brain during the last trimester of pregnancy. “These babies have low concentrations of DHA in their brain tissue, which may contribute to poorer cognitive outcomes,” Dr. Gould said.
    The study followed 323 infants born before 29 weeks’ gestation, who were given 60mg of DHA/kg per day via enteral or control tube feeding.
    They were compared with 333 children in the control group, who received an emulsion with no DHA. At five years old, children in both groups underwent the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) IQ test.
    “On average, those in the DHA group scored 3.5 points higher on the IQ scale than those in the control group,” Dr. Gould said.
    “These very promising results suggest DHA has the potential to improve cognitive performance when administered via emulsion for infants born before 29 weeks’ gestation.”
    Crossword puzzles beat computer video games in slowing memory lossColumbia University Irving Medical Center & Duke University, October 27, 2022
    A new study by researchers from Columbia University and Duke University published in the journal NEJM Evidence shows that doing crossword puzzles has an advantage over computer video games for memory functioning in older adults with mild cognitive impairment.
    In a randomized, controlled trial, led by D.P. Devanand, MD, professor of psychiatry and neurology at Columbia, with Murali Doraiswamy, MD, professor of psychiatry and medicine at Duke, researchers determined that participants (average age 71) trained in doing web-based crossword puzzles demonstrated greater cognitive improvement than those who were trained on cognitive video games.
    “This is the first study
    1 hr 3 min
  • The Gary Null Show - 10.27.22
    Videos:
    A.I. Is Making it Easier to Kill (You). Here’s How. | NYT (10:00)
    Disturbing simulation shows power, terror of killer robots (7:46)
    Fear Psychosis and the Cult of Safety – Why are People so Afraid? (13:25)
     
    Peanuts Linked to Lower Breast Cancer Risk
    Washington University in St. Louis & Harvard University, October 22, 2022
    Girls ages 9 to 15 who regularly ate peanut butter or nuts were 39 percent less likely to develop benign breast disease by age 30, according to a new study.
    Benign breast disease, although noncancerous, increases risk of breast cancer later in life.
    “These findings suggest that peanut butter could help reduce the risk of breast cancer in women,” says senior author Graham Colditz, professor of surgery at Washington University School of Medicine and associate director for cancer prevention and control at Siteman Cancer Center at Barnes-Jewish Hospital.
    Published in the journal Breast Cancer Research and Treatment, the findings are based on the health histories of 9,039 US girls enrolled in the Growing Up Today Study .
    When the study participants were 18 to 30 years old, they reported whether they had been diagnosed with benign breast disease that had been confirmed by breast biopsy.
    Participants who ate peanut butter or nuts two times each week were 39 percent less likely to have developed benign breast disease than those who never ate them.
    The study’s findings suggest that beans, lentils, soybeans, and corn also may help prevent benign breast disease, but consumption of these foods was much lower in these girls so the evidence was weaker.
    Past studies have linked peanut butter, nut, and vegetable fat consumption to a lower risk for benign breast disease. However, participants in those studies were asked to recall their high school dietary intakes years later.
    Perinatal Brain DHA Concentration Has a Lasting Impact on CognitionNational Institute on Alcohol Abuse and Alcoholism October 20, 2022
    A new study on Proteomics is now available. According to news out of Bethesda, Maryland, research stated, “Premature infants are deprived of prenatal accumulation of brain docosahexaenoic acid [DHA (22: 6n-3)], an omega-3 fatty acid [omega-3 FA (n-3 FA)] important for proper development of cognitive function. The resulting brain DHA deficit can be reversed by omega-3 FA supplementation.”
    “The objective was to test whether there is a critical period for providing omega-3 FA to correct cognitive deficits caused by developmental omega-3 FA deprivation in mice. Twelve timed-pregnant mice were fed an omega-3 FA-deficient diet containing 0.04% a-linolenic acid, and their offspring were fed the same deficient diet (Def group) or changed to an omega-3 FA-adequate diet containing 3.1% ALA at 3 wk, 2 mo, or 4 mo of age. In parallel, 3 E14 pregnant mice were fed the adequate diet and their offspring were fed the same diet (Adeq group) throughout the experiment. Brain FA composition, learning and memory, and hippocampal synaptic protein expression were evaluated at 6 mo by gas chromatography, the Morris water maze test, and western blot analysis, respectively.
    Maternal dietary omega-3 FA deprivation decreased DHA by > 50% in the brain of their offspring at 3 wk of age. The Def group showed significantly worse learning and memory at 6 mo than those groups fed the adequate diet. These pups also had decreased hippocampal expression of postsynaptic density protein 95 (43% of Adeq group), Homer protein homolog 1 (21% of Adeq group), and synaptosome-associated protein of 25 kDa (64% of Adeq group).
    Changing mice to the adequate diet at 3 wk, 2 mo, or 4 mo of age restored brain DHA to the age-matched adequate concentration. However, deficits in hippocampal synaptic protein expression and spatial learning and memory were normalized only when the diet was changed at 3 wk.”
    The research concluded: “Developmental deprivation of brain DHA by dietary omega-3 FA depletion in mice may have a lasting impact on cognitive function
    58 min
  • The Gary Null Show - 10.26.22
    Videos :
    Robby Soave: PayPal Threatens To Take $2,500 From Users Who Promote ‘Misinformation’ (9:26)
    ED DOWD: COVID AND THE GLOBAL FINANCIAL COLLAPSE: A TALE OF CATASTROPHES AND COVER-UPS (32:50 – 42:50)
    Tidal energy could be huge – why isn’t it? (4:00)
    Back To the Future of Wind Energy Technology with Paul Gipe (7:23)
    No, this angry AI isn’t fake (see comment), w Elon Musk. (3:24)
    Dr. Bhakdi Clip (7:27)
     
    Study shows inexpensive, readily available chemical (GABA) may limit impact of COVID-19
    University of California, Los Angeles, October 25, 2022
    Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic option for infections with SARS-CoV-2 variants and perhaps future novel coronaviruses.
    A team led by researchers at the David Geffen School of Medicine at UCLA report in Frontiers in Immunology that an amino acid called GABA, which is available over-the-counter in many countries, reduced disease severity, viral load in the lungs, and death rates in SARS-CoV-2-infected mice. This follows up on their previous finding that GABA consumption also protected mice from another lethal mouse coronavirus called MHV-1. In both cases, GABA treatment was effective when given just after infection or several days later near the peak of virus production. The protective effects of GABA against two different types of coronaviruses suggest that GABA may provide a generalizable therapy to help treat diseases induced by new SARS-CoV-2 variants and novel beta-coronaviruses. 
    Their previous studies showed that GABA administration protected mice from developing severe disease after infection with a mouse coronavirus called MHV-1. To more stringently test the potential of GABA as a therapy for COVID-19, they studied transgenic mice that when infected with SARS-CoV-2 develop severe pneumonia with a high mortality rate. “If our observations of the protective effects of GABA therapy in SARS-CoV-2-infected mice are confirmed in clinical trials, GABA could provide an off-the-shelf treatment to help ameliorate infections with SARS-CoV-2 variants. GABA is inexpensive and stable at room temperature, which could make it widely and easily accessible, and especially beneficial in developing countries.”
    The researchers said that GABA and GABA receptors are most often thought of as a major neurotransmitter system in the brain. Years ago, they, as well as other researchers, found that cells of the immune system also possessed GABA receptors and that the activation of these receptors inhibited the inflammatory actions of immune cells. Taking advantage of this property, the authors reported in a series of studies that GABA administration inhibited autoimmune diseases such as type 1 diabetes, multiple sclerosis, and rheumatoid arthritis in mouse models of these ailments.
    Other scientists who study gas anesthetics have found that lung epithelial cells also possess GABA receptors and that drugs that activate these receptors could limit lung injuries and inflammation in the lung. The dual actions of GABA in inflammatory immune cells and lung epithelial cells, along with its safety for clinical use, made GABA a theoretically appealing candidate for limiting the overreactive immune responses and lung damage due to coronavirus infection.
    Working with colleagues at the University of Southern California, the UCLA research team in this study administered GABA to the mice just after infection with SARS-CoV-2, or two days later when the virus levels are near their peak in the mouse lungs. While the vast majority of untreated mice did not survive this infection, those given GABA just after infection, or two days later, had less illness severity and a lower mortality rate over the course of the study. Treated mice also displayed reduced levels of virus in their lungs and changes in circulating immune signaling molecules, known as cytok
    1 hr 3 min
  • The Gary Null Show - 10.25.22
    Video:
    1.Putin just EXPOSED the NATO nuclear plan and they are P*SSED | Redacted w Natali and Clayton Morris 
    2.Reaction To PayPal Threatening To Fine Users $2,500 Over ‘Misinformation’ (4:20)
    3.The Genius Behind PayPal’s Bad Idea (7:36)
    4.Clare Daly Latest Top 7 Contributions in the EU. (First 2 of 7 ) (start @ 1:56)
    5. Tulsi Gabbard Speech LIVE | Tulsi Gabbard Accuses Joe Biden | US News Latest | English News LIVE
     
    Polyphenol consumption in adolescents is associated with better cardiovascular healthUniversity of Barcelona (Spain), October 24, 2022
    The consumption of polyphenols in adolescents is associated with a better cardiovascular health, according to a collaborative research study which includes the University of Barcelona.
    The study has been published in Scientific Reports. As part of the study, the researchers analyzed the amount of polyphenols in the urine of 1,326 adolescents that took part in the SI! Program (Integral Health) of 24 secondary education schools in Madrid and Barcelona.
    Polyphenols are bioactive compounds with antioxidant and anti-inflammatory properties found in several plant-based foods, mainly in fruit, vegetables, nuts and olive oil. To date, there were few studies on the intake of polyphenols in children and adolescents.
    “With the results of this study, we observed that a higher urinary polyphenol excretion is linearly associated with a higher cardiovascular health index in adolescents aged 11-14, specially in children. This cardiovascular health index is defined by the criteria established by the American Heart Association (AHA), which considers seven variables: body mass index, physical activity, smoking, diet, blood pressure, total cholesterol and blood glucose,” says Professor Rosa M Lamuela, director of the Institute for Research in Nutrition and Food Safety of the University of Barcelona
    NAC supplements may benefit cardiovascular health: Human dataUniversity of Marburg (Germany), October 16, 2022Four weeks of supplementation with N-acetylcysteine (NAC) may reduce levels of homocysteine and improve blood pressure, says a new analysis of two randomized, double-blind, placebo-controlled trials.
    A daily dose of 1.8 grams of NAC could lower homocysteine levels by about 12%, and may improve systolic and diastolic blood pressure, according to findings published in the American Journal of Clinical Nutrition .
    Elevated levels of the amino acid homocysteine have been reported to increase the risk of cardiovascular disease. This has led some to point to the potential of the B-vitamins to reduce homocysteine levels and reduce the risk of CVD. B vitamins are cofactors for enzymes involved in homocysteine metabolism and therefore giving people vitamin B supplements is hypothesized to reduce homocysteine levels and therefore reduce cognitive impairment.
    However, clinical trials including participants at risk of, or already suffering from, cardiovascular disease have produced null results, with some experts arguing that short term B vitamin supplementation should not be expected to reverse the long-term development of heart disease.
    “Because recent analyses that controlled for confounders such as statins or folate fortification detected a benefit of folate/B-vitamins for stroke (22–24), homocysteine may conditionally be a therapeutic target,” wrote the authors of the new study, led by Prof Wulf Hildebrandt, formerly with the German Cancer Research Center and now at the University of Marburg (Germany).
    “Therefore, an alternative agent for (more) effective homocysteine lowering may be desirable, especially for conditions in which B-vitamins are ineffective [e.g., in renal disease] or if a reduction in homocysteine of >25% is intended.”
    There is a known link between homocysteine and NAC, and some studies have shown that NAC may reduce levels of the amino acid, but the data is somewhat mixed.
    Results showed that NAC supplementation significant decreased homocysteine levels by an average of 11.7% (
    1 hr 1 min
  • The Gary Null Show - 10.24.22
    Videos:
    The Old World Order Is About To Collapse – Peter Zeihan | Modern Wisdom Podcast 514 (0:20 to 20:00)
    Tulsi Gabbard Speech LIVE | Tulsi Gabbard Accuses Joe Biden | US News Latest | English News LIVE
    Noam Chomsky – The Crimes of U.S. Presidents
    Clare Daly Latest Top 7 Contributions in the EU. (First 1 of 7 ) (start @ 0:17)
     
    Carotenoids linked to lower diabetesUtrecht University Medical Center (Netherlands), October 21, 2022
    A prospective study of 37,846 subjects links higher carotenoid consumption to a lower risk of diabetes.
    People who consume a diet high in antioxidant-rich carotenoids have a lower occurrence of diabetes, according to a new study. The researchers linked higher intakes of beta and alpha carotene with lower risks of type 2 diabetes.
    The research analyzed data from validated food frequency questionnaires from 37,846 participants in the European Prospective Investigation into Cancer and Nutrition, which followed subjects for a mean of 10 years. They focused on dietary carotenoid intake levels consisting of beta-carotene, alpha-carotene, beta-cryptoxanthin, lycopene, lutein, zeaxanthin and the total of these six carotenoids. The study also examined how smoking (tobacco, not carotenoids) played into the subjects’ risk of developing diabetes. Thirty-one percent of the subjects smoked.
    “This study shows that diets high in beta-carotene and alpha-carotene are associated with reduced type 2 diabetes in generally healthy men and women,” concluded the authors of the study, which appeared in the journal Nutrition, Metabolism & Cardiovascular Disease. Smoking, according the researchers’ analysis, made no difference in the risk of diabetes.
    An earlier study linked low carotenoids with increased risk of colon cancer. Animal and human studies have found that beta-carotene can enhance many aspects of immunity. Some of this research has shown that beta-carotene boosts the activity of “natural-killer” cells, a type of immune cell that fights cancer.
    Melatonin and CoQ10 for migrainesUniversity of California, Los Angeles, October 20, 2022
    Migraines affect about 12 percent of people in the United States, occurring more often in women, in people between the ages of 30 and 39, and within families.
    A retrospective analysis of migraine sufferers found that emotional stress was a trigger for 80 percent of them, missing a meal was a trigger for 57 percent, and lack of sleep was a trigger for 50 percent.
    In a study, patients who experienced migraine headaches two to eight times per month were randomly assigned to take either a placebo or 100 milligrams of CoQ10 three times per day for at least three months. The authors measured success as a greater than 50 percent reduction in the frequency of migraines. Only 14.4 percent of those who took the placebo showed this level of reduction, but 47.6 percent of those who took CoQ10 reduced their frequency of migraines by that amount.
    Then there’s the B vitamin riboflavin. Another study found that 59 percent of people who took a daily dose of 400 milligrams had a greater than 50 percent reduction in the frequency of migraines, compared to 15 percent of those who took a placebo. However, it took three months for riboflavin to show this benefit.
    Knowing that sleep problems increase the risk of migraines, researchers compared the effects of 3 milligrams of melatonin to the effects of the anti-depressant amitriptyline or of a placebo. After three months, 54.4 percent of people who took melatonin had a 50 percent or greater reduction in frequency of headaches compared to 39.1 percent in the amitriptyline group and 20 percent in the placebo group.
    Study: Eating foods high in healthy fats helps fight off skin cancerUniversity Medical Center Groningen (Netherlands), October 21, 2022
    A study has found that foods rich in healthy fats can help protect against skin cancer and boost the effectiveness of immunotherapy among skin cancer patients. Results showed that patients who followed the Me
    1 hr 1 min
  • The Gary Null Show - 10.21.22
    VIDEOS:
    The Cost of Denial Clip (17:33)
    Hang On, Bill Gates and Dr. Fauci just did WHAT? | Redacted with Clayton Morris (21:43)
    There is nothing constructive about the pot calling the kettle black. – Clare Daly  (1:17)
    Clinical trial for nicotinamide riboside: Vitamin safely boosts levels of important cell metabolite linked to multiple health benefits
    University of Iowa Health Care, October 10, 2022
    In a clinical trial of nicotinamide riboside (NR), a newly discovered form of Vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell metabolite that is critical for cellular energy production and protection against stress and DNA damage.
    Studies in mice have shown that boosting the levels of this cell metabolite — known as NAD+ — can produce multiple health benefits, including resistance to weight gain, improved control of blood sugar and cholesterol, reduced nerve damage, and longer lifespan. Levels of NAD+ diminish with age, and it has been suggested that loss of this metabolite may play a role in age-related health decline. These findings in animal studies have spurred people to take commercially available NR supplements designed to boost NAD+. However, these over-the-counter supplements have not undergone many clinical trials to see if they work in people.
    The new research, reported in the journal Nature Communications, was led by Charles Brenner, PhD, professor and Roy J. Carver Chair of Biochemistry at the University of Iowa Carver College of Medicine
    The human trial involved six men and six women, all healthy. Each participant received single oral doses of 100 mg, 300 mg, or 1,000 mg of NR in a different sequence with a seven-day gap between doses. After each dose, blood and urine samples were collected and analyzed to measure various NAD+ metabolites in a process called metabolomics. The trial showed that the NR vitamin increased NAD+ metabolism by amounts directly related to the dose, and there were no serious side effects with any of the doses.
    “This trial shows that oral NR safely boosts human NAD+ metabolism,” Brenner says. “We are excited because everything we are learning from animal systems indicates that the effectiveness of NR depends on preserving and/or boosting NAD+ and related compounds in the face of metabolic stresses. Because the levels of supplementation in mice that produce beneficial effects are achievable in people, it appears than health benefits of NR will be translatable to humans safely.”
    Consumption of a bioactive compound from Neem plant could significantly suppress development of prostate cancer
    National University of Singapore, September 29, 2022
    Oral administration of nimbolide, over 12 weeks shows reduction of prostate tumor size by up to 70 per cent and decrease in tumor metastasis by up to 50 per cent
    A team of international researchers led by Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine at the National University of Singapore (NUS) has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant or curry leaf common in throughout Indian cuisine, could reduce the size of prostate tumor by up to 70 per cent and suppress its spread or metastasis by half.
    In this research, we have demonstrated that nimbolide can inhibit tumor cell viability — a cellular process that directly affects the ability of a cell to proliferate, grow, divide, or repair damaged cell components — and induce programmed cell death in prostate cancer cells,” said Assoc Prof Sethi.
    The researchers observed that upon the 12 weeks of administering nimbolide, the size of prostate cancer tumor was reduced by as much as 70 per cent and its metastasis decreased by about 50 per cent, without exhibiting any significant adverse effects. “This is possible because a direct target of nimbolide in prostate cancer is glutathione reductase, an enzyme which
    1 hr 3 min

About The Gary Null Show

From the publisher's feed

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.

Best of The Gary Null Show

Ranked by our users in the last 21 days

More shows like The Gary Null Show

THE SAVAGE NATION by Michael Savage

THE SAVAGE NATION

11,842 Listeners

The Jimmy Dore Show by Jimmy Dore

The Jimmy Dore Show

3,939 Listeners

Peak Prosperity by Chris Martenson

Peak Prosperity

564 Listeners

Wise Traditions by Weston A. Price Foundation

Wise Traditions

2,314 Listeners

Progressive Commentary Hour by Progressive Radio Network

Progressive Commentary Hour

118 Listeners

Geopolitics & Empire by Geopolitics & Empire

Geopolitics & Empire

492 Listeners

Bannon`s War Room by WarRoom.org

Bannon`s War Room

16,524 Listeners

SGT Report’s The Propaganda Antidote by SGT Report

SGT Report’s The Propaganda Antidote

1,331 Listeners

Redacted News by Redacted.inc

Redacted News

665 Listeners

The Way Forward with Alec Zeck by The Way Forward

The Way Forward with Alec Zeck

906 Listeners

Gary Null Mastering Life Series by gnmasteringlifeseries

Gary Null Mastering Life Series

20 Listeners

THE MCCULLOUGH REPORT by Dr. Peter McCullough

THE MCCULLOUGH REPORT

2,435 Listeners

Sarah Westall - Business Game Changers by Sarah Westall

Sarah Westall - Business Game Changers

238 Listeners

The Mel K Show by Mel K

The Mel K Show

544 Listeners

Man in America Podcast by Man in America

Man in America Podcast

512 Listeners